Andrew H. Sims

8.2k citations

120 papers · 6.3k · 2 hit papers · h-index 41

Impact in

Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Oncology top 1%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers

Papers in

Oncology 54
- Cancer Cells and Metastasis 24
- Cancer-related Molecular Pathways 9
- HER2/EGFR in Cancer Research 7
Cancer Research 31
- Breast Cancer Treatment Studies 14
- Cancer Genomics and Diagnostics 9

Co-authors: Robert B. Clarke (21 shared papers)J. Michael Dixon (13 shared papers)Anthony Howell (11 shared papers)David James Harrison (14 shared papers)Çiğdem Selli (8 shared papers)Göran Landberg (7 shared papers)Arran Turnbull (15 shared papers)Richard R. Meehan (5 shared papers)
Journals: Breast Cancer Research (10 papers)PLoS ONE (6 papers)Cancer Research (6 papers)Clinical Cancer Research (5 papers)Oncogene (5 papers)
Partner nations: United Kingdom United States Italy

In The Last Decade

Andrew H. Sims

120 papers receiving 6.2k citations

Andrew H. Sims's Hit Papers

align trajectories log scale

Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets 2019 · 743 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2019 Cancer Cell
2015 Nature Communications

Peers

Countries citing papers authored by Andrew H. Sims

Since Specialization

Citations

This map shows the geographic impact of Andrew H. Sims's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew H. Sims with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew H. Sims more than expected).

Fields of papers citing papers by Andrew H. Sims

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew H. Sims. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew H. Sims. The network helps show where Andrew H. Sims may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew H. Sims, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew H. Sims Line = papers co-authored together Andrew H. Sims links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets Cancer Cell ·Luca Cassetta, Stamatina Fragkogianni, Andrew H. Sims, Agnieszka Swierczak, Lesley M. Forrester, Hui Zhang, Daniel Y. H. Soong, Tiziana Cotechini Hit paper breakdown →	2019	743
2	MEG3 long noncoding RNA regulates the TGF-β pathway genes through formation of RNA–DNA triplex structures Nature Communications ·Tanmoy Mondal, Santhilal Subhash, Roshan Vaid, Stefan Enroth, Sireesha Uday, Björn Reinius, Sanhita Mitra, Arif Mohammed Hit paper breakdown →	2015	558
3	Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity Cell ·Alan Serrels, Tom Lund, Bryan Serrels, Adam Byron, Rhoanne C. McPherson, Alex von Kriegsheim, Laura Gómez-Cuadrado, Marta Canel	2015	340
4	Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity Cell Reports ·Bruno M. Simões, Ciara O’Brien, Rachel Eyre, Andreia Machado da Silva, Ling Yu, Aida Sarmiento-Castro, Denis Alférez, Katherine T. Spence	2015	163
5	MCL-1 is a prognostic indicator and drug target in breast cancer Cell Death and Disease ·Kirsteen J. Campbell, Sandeep Dhayade, Nicola Ferrari, Andrew H. Sims, Emma R. Johnson, Susan M. Mason, Ashley Dickson, Kevin M. Ryan	2018	156
6	Immune Cell Gene Signatures for Profiling the Microenvironment of Solid Tumors Cancer Immunology Research ·Ajit J. Nirmal, Tim W. Regan, Barbara Bo-Ju Shih, David Hume, Andrew H. Sims, Tom C. Freeman	2018	153
7	Origins of breast cancer subtypes and therapeutic implications Nature Clinical Practice Oncology ·Andrew H. Sims, Anthony Howell, Sacha Jon Howell, Robert B. Clarke	2007	147
8	Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns Genome biology ·Duncan Sproul, Robert R. Kitchen, Colm E. Nestor, J. Michael Dixon, Andrew H. Sims, David James Harrison, Bernard H. Ramsahoye, Richard R. Meehan	2012	144
9	Wnt Pathway Activity in Breast Cancer Sub-Types and Stem-Like Cells PLoS ONE ·Rebecca S. Lamb, Matthew P. Ablett, Katherine T. Spence, Göran Landberg, Andrew H. Sims, Robert B. Clarke	2013	139
10	Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth The Journal of Experimental Medicine ·Ruoyu Ma, Hui Zhang, Xuefeng Li, Chengbin Zhang, Çiğdem Selli, Giulia Tagliavini, Alyson D. Lam, Sandrine Prost	2020	129
11	The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets – improving meta-analysis and prediction of prognosis BMC Medical Genomics ·Andrew H. Sims, Graeme J. Smethurst, Y. Hey, Michal J. Okoniewski, Stuart De V. Pepper, Anthony Howell, Crispin J. Miller, Robert B. Clarke	2008	123
12	Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer Proceedings of the National Academy of Sciences ·Duncan Sproul, Colm E. Nestor, Jayne Culley, Jacqueline H. Dickson, J. Michael Dixon, David James Harrison, Richard R. Meehan, Andrew H. Sims	2011	122
13	Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling Nature Communications ·Rachel Eyre, Denis Alférez, Angélica Santiago-Gómez, Katherine T. Spence, James C. McConnell, Claire Alexandre Hart, Bruno M. Simões, Diane V. Lefley	2019	122
14	KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals Oncogene ·Susana Moleirinho, Nan‐Shan Chang, Andrew H. Sims, Andrew Tilston-Lünel, Liselotte Angus, Andrew J. Steele, V Boswell, Susan Carol Barnett	2012	112
15	Cyclin D1, Id1 and EMT in breast cancer BMC Cancer ·Nicholas P. Tobin, Andrew H. Sims, Katja Lundgren, Sophie Lehn, Göran Landberg	2011	88
16	Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer Journal of Clinical Oncology ·Arran Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Anita K. Dunbier, Jeremy St J Thomas, Mitch Dowsett	2015	81
17	The Embryonic Transcription Cofactor LBH Is a Direct Target of the Wnt Signaling Pathway in Epithelial Development and in Aggressive Basal Subtype Breast Cancers Molecular and Cellular Biology ·Megan E. Rieger, Andrew H. Sims, Ebony R. Coats, Robert B. Clarke, Karoline J. Briegel	2010	76
18	PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer PLoS ONE ·Sherene Loi, Stefan Michiels, José Baselga, Sandeep Kumar Singhal, Vicky S. Sabine, Andrew H. Sims, Tarek Sahmoud, J. Michael Dixon	2013	76
19	Transcriptome Analysis of Recombinant Protein Secretion by Aspergillus nidulans and the Unfolded-Protein Response In Vivo Applied and Environmental Microbiology ·Andrew H. Sims, Manda E. Gent, Karin Lanthaler, Nigel Stuart Dunn-Coleman, Stephen G. Oliver, Geoffrey D. Robson	2005	74
20	The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs) Journal of Experimental & Clinical Cancer Research ·Rosamaria Lappano, Marianna Talia, Francesca Cirillo, Damiano Cosimo Rigiracciolo, Domenica Scordamaglia, Rita Guzzi, Anna Miglietta, Ernestina Marianna De Francesco	2020	73

About Andrew H. Sims

Andrew H. Sims is a scholar working on Oncology, Cancer Research, Molecular Biology, Genetics and Immunology and Allergy, having authored 120 papers that have together received 6.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (24 papers), Breast Cancer Treatment Studies (14 papers), Estrogen and related hormone effects (12 papers), Gene expression and cancer classification (10 papers), Cancer Genomics and Diagnostics (9 papers), Cancer-related Molecular Pathways (9 papers), Epigenetics and DNA Methylation (8 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (2.0k citations), Immunology (1.0k citations), Molecular Biology (3.3k citations) and Immunology and Allergy (248 citations). Andrew H. Sims has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Robert B. Clarke, J. Michael Dixon, Anthony Howell, David James Harrison, Çiğdem Selli, Göran Landberg, Arran Turnbull, Richard R. Meehan, Sacha Jon Howell and Simon P. Langdon. Their work appears in journals such as Breast Cancer Research, PLoS ONE, Cancer Research, Clinical Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Andrew H. Sims

Impact in

Papers in i

In The Last Decade

Andrew H. Sims

Andrew H. Sims's Hit Papers

Peers

Countries citing papers authored by Andrew H. Sims

Fields of papers citing papers by Andrew H. Sims

All Works

About Andrew H. Sims

Explore authors with similar magnitude of impact

Papers in